Stay updated on Clinical Trial: Weekly SC Pemziviptadil in Symptomatic PAH
Sign up to get notified when there's something new on the Clinical Trial: Weekly SC Pemziviptadil in Symptomatic PAH page.

Latest updates to the Clinical Trial: Weekly SC Pemziviptadil in Symptomatic PAH page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new Revision: v3.3.3 appears in the page history, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed from the footer/history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe history now includes a new revision entry v3.3.2 and removes the prior entry v3.2.0.SummaryDifference0.1%

- Check45 days agoChange DetectedRemoved a generic notice about government funding and operating status from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check60 days agoChange DetectedThe new screenshot appears to reflect a UI refresh of the Record History page without altering any version entries or study status.SummaryDifference0.1%

- Check88 days agoChange DetectedMajor update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.SummaryDifference11%

- Check95 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial: Weekly SC Pemziviptadil in Symptomatic PAH
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Weekly SC Pemziviptadil in Symptomatic PAH page.